Inventor
MOELLEKEN JOERG
DE23 patents
⚠️ This page may combine multiple inventors who share the name “MOELLEKEN JOERG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
20 patentsUS9714292B2Jul 25, 2017
Bispecific antibodies against human TWEAK and human IL17 and uses thereof
HOFFMANN LA ROCHE21 citations93
US10822402B2Nov 3, 2020
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US9862763B2Jan 9, 2018
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US9309319B2Apr 12, 2016
Antibodies against human IL33R and uses thereof
HOFFMANN LA ROCHE8 citations83
US10538585B2Jan 21, 2020
Anti-ANG2 antibodies and methods of use
HOFFMANN LA ROCHE2 citations72
US10730938B2Aug 4, 2020
Bispecific antibodies and methods of use in ophthalmology
HOFFMANN LA ROCHE3 citations71
US10087246B2Oct 2, 2018
Anti-PDGF-B antibodies and methods of use
HOFFMANN LA ROCHE2 citations71
US11958912B2Apr 16, 2024
Method for determining the in vivo interaction mode
HOFFMANN LA ROCHE2 citations70
US12297263B2May 13, 2025
Humanized anti-Tau(PS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US11572404B2Feb 7, 2023
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US10329346B2Jun 25, 2019
TNFa-IL-17 bispecific antibodies
HOFFMANN LA ROCHE1 citations62
US11866490B2Jan 9, 2024
Antibody that binds to VEGF and IL-1beta and methods of use
HOFFMANN LA ROCHE0 citations60
US11130804B2Sep 28, 2021
Antibody that binds to VEGF and IL-1beta and methods of use
HOFFMANN LA ROCHE0 citations60
US12522653B2Jan 13, 2026
Antibody that binds to VEGF-A and ANG2 and methods of use
HOFFMANN LA ROCHE0 citations59
US12287335B2Apr 29, 2025
Direct affinity measurement of human IgG1 binding multimeric antigens
HOFFMANN LA ROCHE0 citations59
US11732036B2Aug 22, 2023
Antibody that binds to VEGF-A and ANG2 and methods of use
HOFFMANN LA ROCHE0 citations59
US11820816B2Nov 21, 2023
Anti-VEGF antibodies and methods of use
HOFFMANN LA ROCHE0 citations58
US12103967B2Oct 1, 2024
Bispecific anti-CCL2 antibodies
HOFFMANN LA ROCHE0 citations56
US11739142B2Aug 29, 2023
Bispecific anti-CCL2 antibodies
HOFFMANN LA ROCHE1 citations56
US12157770B2Dec 3, 2024
Anti-HLA-G antibodies and methods of use thereof
HOFFMANN LA ROCHE0 citations48